MCID: SWL001
MIFTS: 38

Swallowing Disorders

Categories: Gastrointestinal diseases, Neuronal diseases

Aliases & Classifications for Swallowing Disorders

MalaCards integrated aliases for Swallowing Disorders:

Name: Swallowing Disorders 53 42
Deglutition Disorders 71

Classifications:



External Ids:

UMLS 71 C0011168

Summaries for Swallowing Disorders

NINDS : 53 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary : Swallowing Disorders, also known as deglutition disorders, is related to sucking/swallowing disorder not related with pierre robin syndrome and sucking/swallowing disorder associated with a neuromuscular disease, and has symptoms including seizures, vomiting and nausea and vomiting. The drugs Acetaminophen and Remifentanil have been mentioned in the context of this disorder. Affiliated tissues include brain, tongue and testes.

MedlinePlus : 42 If you have a swallowing disorder, you may have difficulty or pain when swallowing. Some people cannot swallow at all. Others may have trouble swallowing liquids, foods, or saliva. This makes it hard to eat. Often, it can be difficult to take in enough calories and fluids to nourish your body. Anyone can have a swallowing disorder, but it is more common in older adults. It often happens because of other conditions, including Nervous system disorders, such as Parkinson's disease and cerebral palsy Problems with your esophagus, including GERD (gastroesophageal reflux disease) Stroke Head or spinal cord injury Cancer of the head, neck, or esophagus Medicines can help some people, while others may need surgery. Swallowing treatment with a speech-language pathologist can help. You may find it helpful to change your diet or hold your head or neck in a certain way when you eat. In very serious cases, people may need feeding tubes. NIH: National Institute on Deafness and Other Communication Disorders

Wikipedia : 74 Dysphagia is difficulty in swallowing. Although classified under "symptoms and signs" in ICD-10, in some... more...

Related Diseases for Swallowing Disorders

Diseases related to Swallowing Disorders via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 103)
# Related Disease Score Top Affiliating Genes
1 sucking/swallowing disorder not related with pierre robin syndrome 12.3
2 sucking/swallowing disorder associated with a neuromuscular disease 12.3
3 sucking/swallowing disorder associated with cerebellar anomalies 12.3
4 sucking/swallowing disorder associated with posterior fossa anomalies 12.3
5 sucking/swallowing disorder associated with basal ganglia anomalies 12.3
6 sucking/swallowing disorder associated with suprabulbar anomalies 12.3
7 sucking/swallowing disorder associated with neurologic anomalies 12.3
8 sucking/swallowing disorder associated to cervicofacial or esophageal malformation 12.3
9 syndromic sucking/swallowing disorder with unidentifyed syndrome 12.3
10 sucking/swallowing disorder associated to a chromosomal anomaly 12.3
11 sucking/swallowing disorder associated with an identified syndrome 12.3
12 traumatic brain injury 11.2
13 dysphagia 10.8
14 aspiration pneumonia 10.4
15 stroke, ischemic 10.2
16 gastroesophageal reflux 10.1
17 neuromuscular disease 10.1
18 aphasia 10.0
19 brain injury 10.0
20 parkinson disease, late-onset 10.0
21 speech and communication disorders 10.0
22 respiratory failure 10.0
23 dementia 10.0
24 cerebral palsy 10.0
25 myopathy 10.0
26 dystonia 10.0
27 speech disorder 10.0
28 oral cancer 10.0
29 head injury 10.0
30 ocular motor apraxia 9.9
31 pierre robin syndrome 9.9
32 tardive dyskinesia 9.9
33 esophageal atresia 9.9
34 hyperostosis 9.9
35 pneumonia 9.9
36 cerebrovascular disease 9.9
37 oropharynx cancer 9.9
38 myotonic dystrophy 9.9
39 isolated pierre robin sequence 9.9
40 alcohol dependence 9.7
41 autoimmune disease 9.7
42 machado-joseph disease 9.7
43 esophageal cancer 9.7
44 huntington disease 9.7
45 lymphatic malformation 5 9.7
46 oculopharyngeal muscular dystrophy 9.7
47 rheumatoid arthritis 9.7
48 schizophrenia 9.7
49 tracheoesophageal fistula with or without esophageal atresia 9.7
50 down syndrome 9.7

Comorbidity relations with Swallowing Disorders via Phenotypic Disease Network (PDN): (show top 50) (show all 58)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Alzheimer Disease
Bronchitis Bronchopneumonia
Cerebral Atherosclerosis Cerebral Degeneration
Cerebrovascular Disease Conjunctivitis
Decubitus Ulcer Deficiency Anemia
Dyskinesia of Esophagus Encephalopathy
Epilepsy, Focal, with Speech Disorder and with or Without Mental Retardation Esophageal Cancer
Esophageal Candidiasis Esophageal Disease
Esophagitis Facial Paralysis
Familial Atrial Fibrillation Generalized Atherosclerosis
Heart Disease Hypertension, Essential
Hypothyroidism Intermittent Claudication
Intracranial Embolism Intracranial Thrombosis
Iron Deficiency Anemia Kidney Disease
Kwashiorkor Larynx Cancer
Major Depressive Disorder Malignant Essential Hypertension
Marasmus Megaesophagus
Neurogenic Bladder Neuromuscular Disease
Nutritional Deficiency Disease Obstructive Hydrocephalus
Ocular Motor Apraxia Oral Candidiasis
Osteoporosis Paralytic Ileus
Parkinson Disease, Late-Onset Peripheral Vascular Disease
Pharyngitis Pharynx Cancer
Progressive Bulbar Palsy Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Swallowing Disorders:



Diseases related to Swallowing Disorders

Symptoms & Phenotypes for Swallowing Disorders

UMLS symptoms related to Swallowing Disorders:


seizures, vomiting, nausea and vomiting, abdominal pain, constipation, headache, diarrhea, pseudobulbar signs, nausea, icterus, signs and symptoms, digestive, dyspepsia, heartburn, gastrointestinal gas, digestive system symptom, flatulence, eructation, and gas pain, symptoms involving digestive system, other symptoms involving digestive system, odynophagia, pain in esophagus (finding), absent deglutition, swallowing problems, choking sensation, symptom as reason for upper g.i. examination, dysphagia, pharyngeal phase, dysphagia, pharyngoesophageal phase

Drugs & Therapeutics for Swallowing Disorders

Drugs for Swallowing Disorders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 163)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetaminophen Approved Phase 4 103-90-2 1983
2
Remifentanil Approved Phase 4 132875-61-7 60815
3
Lisinopril Approved, Investigational Phase 4 76547-98-3, 83915-83-7 5362119
4
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
5
Histamine Approved, Investigational Phase 4 51-45-6 774
6
Cyproheptadine Approved Phase 4 129-03-3 2913
7 Antipyretics Phase 4
8 Carboxymethylcellulose Sodium Phase 4
9
protease inhibitors Phase 4
10 HIV Protease Inhibitors Phase 4
11 Gastrointestinal Agents Phase 4
12 Protective Agents Phase 4
13 Dermatologic Agents Phase 4
14 Neurotransmitter Agents Phase 4
15 Cardiotonic Agents Phase 4
16 Antihypertensive Agents Phase 4
17 Angiotensin-Converting Enzyme Inhibitors Phase 4
18 Histamine Antagonists Phase 4
19 Histamine H1 Antagonists Phase 4
20 Anti-Allergic Agents Phase 4
21
Histamine Phosphate Phase 4 51-74-1 65513
22
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
23
Rabeprazole Approved, Investigational Phase 2, Phase 3 117976-89-3 5029
24
Zinc Approved, Investigational Phase 3 7440-66-6 32051
25
Fluorouracil Approved Phase 3 51-21-8 3385
26
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
27
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
28
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
29
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
30 Prednisolone acetate Approved, Vet_approved Phase 3 52-21-1
31
Polaprezinc Experimental Phase 3 107667-60-7
32
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
33 Immunologic Factors Phase 3
34 Immunosuppressive Agents Phase 3
35 Antimetabolites Phase 3
36 Methylprednisolone Acetate Phase 3
37 Neuroprotective Agents Phase 3
38 Pharmaceutical Solutions Phase 3
39
Menthol Approved Phase 2 2216-51-5 16666
40
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
41
Carboplatin Approved Phase 2 41575-94-4 10339178 38904 498142
42
Omeprazole Approved, Investigational, Vet_approved Phase 2 73590-58-6 4594
43
Capsaicin Approved Phase 2 404-86-4 1548943
44
Modafinil Approved, Investigational Phase 2 68693-11-8 4236
45
Prucalopride Approved Phase 2 179474-81-8
46
Lidocaine Approved, Vet_approved Phase 2 137-58-6 3676
47
Esomeprazole Approved, Investigational Phase 2 161796-78-7, 119141-88-7, 161973-10-0 9568614 4594
48
Amifostine Approved, Investigational Phase 2 20537-88-6 2141
49
Piperine Investigational Phase 1, Phase 2 94-62-2 638024
50 Cytochrome P-450 Enzyme Inhibitors Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 350)
# Name Status NCT ID Phase Drugs
1 Does Opioid Induced Swallowing Difficulty Lead to Elevated Risk for Pulmonary Aspiration? Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
2 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
3 Effect of Pharyngeal Inhibition Induced by Repetitive Transcranial Stimulation in Post Stroke Dysphagia Completed NCT01081444 Phase 4
4 Neuromuscular Electroestimulation and Respiratory Muscle Training in the Management of Dysphagia of Subacute Stroke Patients Completed NCT02473432 Phase 4
5 Efficacy of IV vs Oral Administration of Acetaminophen for Pain Control Following Tonsillectomy With or Without Adenoidectomy Completed NCT01721486 Phase 4 IV acetaminophen;PO acetaminophen
6 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
7 Effect of Early Nutritional Therapy on Frailty, Functional Outcomes and Recovery of Undernourished Medical Inpatients Trial: The EFFORT Trial Completed NCT02517476 Phase 4
8 Impact of Single Dose Perioperative Steroids on Dysphagia Following Anterior Cervical Spine Surgery: A Randomized, Prospective, Double-Blind Study Recruiting NCT03711474 Phase 4 Dexamethasone;Saline
9 A Randomized Placebo Controlled Trial of Low Dose Angiotensin Converting Enzyme Inhibitor to Prevent Pneumonia in Older People Who Require Tube Feeding Because of Neurological Dysphagia Terminated NCT02358642 Phase 4 Angiotensin converting enzyme inhibitor (Lisinopril);Placebo
10 Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills Terminated NCT03588806 Phase 4 Xtampza ER (oxycodone)
11 Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding Disorders Terminated NCT02568007 Phase 4 Cyproheptadine
12 Impact of Early Percutaneous Tracheostomy on the Incidence of Swallowing Dysfunction in Critically Ill Patients on Mechanical Ventilation. A Randomized Clinical Trial Unknown status NCT01268423 Phase 3
13 The Comparison of Value of Brachytherapy and Endoscopic Stenting With SEMS in Palliative Treatment of Dysphagia Resulting From Adenocarcinoma of the Esophago-Gastric Junction Unknown status NCT01786278 Phase 2, Phase 3
14 A Randomised Controlled Trial of Dysphagia Therapies for Swallowing Disorders Following Stroke. Completed NCT00257764 Phase 2, Phase 3
15 Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study Completed NCT01279837 Phase 2, Phase 3
16 A Randomized, Prospective Trial of Electrosurgical Incision Followed by Rabeprazole Versus Bougie Dilation Followed by Rabeprazole of Symptomatic Lower Esophageal (Schatzki's) Rings Completed NCT00204750 Phase 2, Phase 3
17 Study for the Evaluation of the Impact of HEPILOR on the Possible Delay in the Development of Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy on the Breast/Thoracic Wall and Lymph Node Drainage. Completed NCT03997188 Phase 3
18 A Randomized Controlled Trial of NMES vs. Traditional Dysphagia Therapy After Stroke Completed NCT01279824 Phase 2, Phase 3
19 A Randomised Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated With Radiotherapy vs ChemoRadiotherapy. Completed NCT00193882 Phase 3 Cisplatin;5-Fluorouracil
20 Evaluation of the Effect of the Consumption of a Hypercaloric/Hyperproteic Formula in the Coverage of Nutritional Requirements in Patients With Chewing/Swallowing Problems That Require a Shredded Diet. Active, not recruiting NCT03727191 Phase 3
21 The Effects of Intraoperative Local and Systemic Corticosteroid Administration on Postoperative Dysphagia After Anterior Cervical Fusion Active, not recruiting NCT03311425 Phase 3 Methylprednisolone;Dexamethasone
22 Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia Terminated NCT01971320 Phase 3
23 Effect of Intravenous Corticosteroid Injections on Dysphagia After Anterior Cervical Spine Surgery: a Randomized, Double-blind, Placebo-controlled Study Terminated NCT02266797 Phase 3 Dexamethasone
24 Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects Terminated NCT00000362 Phase 3
25 The Efficacy of Intensive Nutritional Supplement in Patient With Stroke: a Prospective Randomized Controlled Trial Terminated NCT01810263 Phase 2, Phase 3
26 Phase 2 Study of rTMS on Poststroke Dysphagia Unknown status NCT02090231 Phase 2
27 Swallowing Rehabilitation of Dysphagic Tracheostomized Patients Under Mechanical Ventilation at Intensive Care Unit Unknown status NCT01496924 Phase 2
28 Effectiveness of Acupuncture-like Transcutaneous Nerve Stimulation (ALTENS) in Improving Dysphagia and Associated Symptoms of Chemotherapy and/or Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancers: A Pilot Study Unknown status NCT01697891 Phase 1, Phase 2
29 Effect of Natural Agonists of TRPV1 in the Treatment of Functional Oropharyngeal Dysphagia in Neurological Diseases and the Elderly: Piperine Completed NCT01383694 Phase 1, Phase 2 Piperine
30 Effects of Age and Age-Related Diseases on Swallowing Completed NCT00038350 Phase 2
31 Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts Completed NCT00773227 Phase 2
32 A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia Completed NCT00376506 Phase 2
33 Pilot Study of Transcranial Direct Current Stimulation for Facilitating Swallowing Improvement After an Acute Unilateral Hemispheric Infarction Completed NCT01132066 Phase 1, Phase 2
34 Treatment of Dysphagia Using the Mendelsohn Maneuver Completed NCT00592761 Phase 1, Phase 2
35 Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging Completed NCT03050957 Phase 2
36 Efficacy of Functional Electrical Stimulation in Dysphagia of Nasopharyngeal Cancer Post Radiotherapy Completed NCT00815087 Phase 2
37 Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy Completed NCT00332865 Phase 1, Phase 2
38 Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer Completed NCT02075385 Phase 2
39 A Phase 2 Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) in the Reduction of Dysphagia in Patients Receiving Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Completed NCT00094861 Phase 2 Palifermin;Placebo;Paclitaxel;Carboplatin
40 Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation Completed NCT00426595 Phase 2 Administration of omeprazole suspension;omeprazole administered as a multi-unit-pellet system
41 Effectiveness of a New Neuromuscular Electrical Stimulation (NMES) Treatment Technique (VitalStim® Therapy) in the Management of Young Infants With Severe Dysphagia: a Prospective Pilot Study Completed NCT01723358 Phase 2
42 Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia Completed NCT01085903 Phase 2 Modafinil;Placebo
43 Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia (OD). A Randomized Controlled Trial. Completed NCT01777672 Phase 2
44 Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer Completed NCT01032928 Phase 2
45 Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study Completed NCT03244553 Phase 2 Prucalopride
46 Tongue Pressure Profile Training for Dysphagia Post Stroke Completed NCT01370083 Phase 2
47 Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer Completed NCT01262560 Phase 2 Manuka honey in liquid form;Manuka honey in lozenge form;Standard supportive care
48 Induction of Volitional Swallowing in Chronic Dysphagia Post Stroke: A Novel Mechanism-Based Intervention Completed NCT00306501 Phase 2
49 Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Recruiting NCT02927691 Phase 2
50 Mobile Delivery of an Adherence Program for Head and Neck Cancer Patients Being Treated in Community Care Settings Recruiting NCT04003051 Phase 2

Search NIH Clinical Center for Swallowing Disorders

Genetic Tests for Swallowing Disorders

Anatomical Context for Swallowing Disorders

MalaCards organs/tissues related to Swallowing Disorders:

40
Brain, Tongue, Testes, Spinal Cord, Lung, Cortex, Breast

Publications for Swallowing Disorders

Articles related to Swallowing Disorders:

(show top 50) (show all 1224)
# Title Authors PMID Year
1
Guidelines of clinical practice for the management of swallowing disorders and recent dysphonia in the context of the COVID-19 pandemic. 42 61
32332004 2020
2
Respiratory muscle training in stroke patients with respiratory muscle weakness, dysphagia, and dysarthria - a prospective randomized trial. 42
32150072 2020
3
Evaluation of the association between orofacial pain and dysphagia. 42
32224568 2020
4
Resolution of anemia and improved quality of life following laparoscopic hiatal hernia repair. 61
31399944 2020
5
Swallowing dıfficulty and swallowing anxiety in patients with type-II diabetes mellitus. 61
32189071 2020
6
Moving Forward with Dysphagia Care: Implementing Strategies during the COVID-19 Pandemic and Beyond. 61
32519150 2020
7
Impairments in Food Oral Processing in Patients Treated for Tongue Cancer. 61
31598793 2020
8
Approach to Feeding Difficulties in Neonates and Infants: A Comprehensive Overview. 61
32439111 2020
9
Effects of Carbonation and Temperature on Voluntary Swallowing in Healthy Humans. 61
32556801 2020
10
Pharmacokinetic similarity demonstrated after crushing of the elbasvir/grazoprevir fixed-dose combination tablet for HCV infection. 61
32544221 2020
11
Effect of Protective Cover on the Quality of Life of Patients With Tracheostomy-A Quasi-Experimental Study. 61
32386939 2020
12
Fiberoptic Endoscopic Evaluation of Swallowing in Patients with Type 2 Diabetes Who Have Self-Reported Swallowing Difficulties. 61
32434209 2020
13
Anodal transcranial direct current stimulation and intermittent theta-burst stimulation improve deglutition and swallowing reproducibility in elderly patients with dysphagia. 61
31975493 2020
14
Swallowing disorders following free jejunal flap reconstruction of circumferential pharyngeal defect: Does Botox help? 61
32135435 2020
15
The role of extensional rheology in the oral phase of swallowing: an in vitro study. 61
32373829 2020
16
Post-stroke Complications and Mortality in Burkinabè Hospitals: Relationships with Deglutition Disorders and Nutritional Status. 61
32303906 2020
17
High-Resolution Pharyngeal Manometry and Impedance: Protocols and Metrics-Recommendations of a High-Resolution Pharyngeal Manometry International Working Group. 61
31168756 2020
18
Can We Reduce Frame Rate to 15 Images per Second in Pediatric Videofluoroscopic Swallow Studies? 61
31165922 2020
19
Interventions for Feeding and Swallowing Disorders in Adults with Intellectual Disability: A Systematic Review of the Evidence. 61
31372756 2020
20
Criteria to assess tongue strength for predicting penetration and aspiration in patients with stroke having dysphagia. 61
32329588 2020
21
Effects of transcutaneous neuromuscular electrical stimulation on swallowing disorders: a systematic review and meta-analysis. 61
32209833 2020
22
Providing optimal nursing care for patients undergoing enteral feeding. 61
32103650 2020
23
A service evaluation of parent adherence with dysphagia management therapy guidelines: reports from family carers supporting children with complex needs in Greece. 61
30222368 2020
24
Improvement of Swallowing Function After Surgical Treatment of Diffuse Idiopathic Skeletal Hyperostosis: Our Experience. 61
31470164 2020
25
Implementing a flexible endoscopic evaluation of swallowing at elderly care facilities to reveal characteristics of elderly subjects who screened positive for a swallowing disorder. 61
32088014 2020
26
The role of body mass index in determining clinical and quality of life outcomes after laparoscopic anti-reflux surgery. 61
31062159 2020
27
Persistent Feeding and Swallowing Deficits in a Mouse Model of 22q11.2 Deletion Syndrome. 61
32082240 2020
28
Long-term evaluation of satisfaction and side effects after modified uvulopalatopharyngoplasty. 61
30861139 2020
29
Oral health status in pediatric patients with cerebral palsy fed by oral versus enteral route. 61
31697430 2020
30
The prevalence and types of oral- and pharyngeal-stage dysphagia in patients with demyelinating diseases based on subjective assessment by the study subjects. 61
31704547 2020
31
Reconsideration of three screening tests for dysphagia in patients with cerebrovascular disease performed by non-expert examiners. 61
31037446 2020
32
Association between Skeletal Muscle Strength and Dysphagia among Chinese Community-Dwelling Elderly Adults. 61
32510118 2020
33
Combined Effects of NMES and Mendelsohn Maneuver on the Swallowing Function and Swallowing-Quality of Life of Patients with Stroke-Induced Sub-Acute Swallowing Disorders. 61
31940930 2020
34
Effects of Motor Imagery and Visual Neurofeedback on Activation in the Swallowing Network: A Real-Time fMRI Study. 61
30771088 2019
35
Swallowing Disorders in the Older Population. 61
31430395 2019
36
Flexible submental sensor patch with remote monitoring controls for management of oropharyngeal swallowing disorders. 61
31853500 2019
37
Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues. 61
31810442 2019
38
Development and Predictors of Sarcopenic Dysphagia during Hospitalization of Older Adults. 61
31888041 2019
39
Clinical Indicators of Impaired Swallowing in Children with Neurological Disorders. 61
31891226 2019
40
Communicative and swallowing disorders in anoxic patients: A retrospective study on clinical outcomes and performance measures. 61
31868687 2019
41
A Double-Blind Randomized Controlled Trial to Determine the Preventive Effect of Hangekobokuto on Aspiration Pneumonia in Patients Undergoing Cardiovascular Surgery. 61
31316037 2019
42
Risk Factors for Dysphagia and the Impact on Outcome After Spontaneous Subarachnoid Hemorrhage. 61
31732847 2019
43
Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube. 61
31722864 2019
44
[Retrospective Examination of Usefulness and Adverse Effects of Tapentadol in Patients with Cancer Pain during Anticancer Treatment]. 61
31748482 2019
45
[Swallowing disorders in the elderly]. 61
31587201 2019
46
Adult Swallowing Disorders: Focus on Quality of Life. 61
31649752 2019
47
[Training Curriculum for the Certificate "Diagnostics and Therapy of Oropharyngeal Dysphagia, including FEES", of the German Society for Phoniatrics and Pedaudiology and the German Society for Otolaryngology, Head and Neck Surgery]. 61
31610597 2019
48
A Device that Models Human Swallowing. 61
30673839 2019
49
Implementation of speech pathology telepractice services for clinical swallowing assessment: An evaluation of service outcomes, costs and consumer satisfaction. 61
31631757 2019
50
Deglutition disorders as a consequence of head and neck cancer therapies: a systematic review and meta-analysis. 61
31230120 2019

Variations for Swallowing Disorders

Expression for Swallowing Disorders

Search GEO for disease gene expression data for Swallowing Disorders.

Pathways for Swallowing Disorders

GO Terms for Swallowing Disorders

Sources for Swallowing Disorders

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....